Home - Products - Others - Other Targets - (Rac)-EC5026

(Rac)-EC5026

CAS No. 1809885-55-9

(Rac)-EC5026( —— )

Catalog No. M37677 CAS No. 1809885-55-9

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with a Ki of 0.06 nM, useful for research on Parkinson's disease and dementia with Lewy Bodies (DLB) .

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	88	Get Quote
5MG	141	Get Quote
10MG	226	Get Quote
25MG	365	Get Quote
50MG	522	Get Quote
100MG	691	Get Quote
500MG	1386	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(Rac)-EC5026
Note

Research use only, not for human use.
Brief Description

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with a Ki of 0.06 nM, useful for research on Parkinson's disease and dementia with Lewy Bodies (DLB) .
Description

(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research ofParkinson's disease and dementia with Lewy Bodies (DLB).
In Vitro

(Rac)-EC5026 inhibits soluble epoxide hydrolase (sEH), with a Ki of 0.06 nM.
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Epoxide Hydrolase
Research Area

——
Indication

——

Chemical Information

CAS Number

1809885-55-9
Formula Weight

405.39
Molecular Formula

C18H23F4N3O3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 250 mg/mL (616.69 mM; Ultrasonic )
SMILES

CCC(C)C(=O)N1CCC(CC1)NC(=O)Nc1ccc(OC(F)(F)F)c(F)c1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Terbufibrol

Terbufibrol reduces the levels of serum total cholesterol in normal and hypercholesterolemic male rats.
Tinurilimab

Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.
Volagidemab

Volagidemab, a monoclonal antibody (mAb) that antagonizes the glucagon receptor (GCGR), is utilized in researching Type 1 Diabetes (T1D) .

Sign In Join Free